Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Human Mutation|April 14, 2022
Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disordersLia DeRoin, Marcela Cavalcante de Andrade Silva, Kristin Petras, et al.Journal of Hematology & Oncology|January 7, 2018
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemiaAmy Y Wang, Howard Weiner, Margaret Green, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2016
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived MalignancyKatarzyna Rojek, Eric Nickels, Barbara Neistadt, et al.Cancer Medicine|August 14, 2019
Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort studyAllison H West, Hayley Knollman, James Dugan, et al.Cancer|December 8, 2015
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemiaJane E Churpek, Rafael Marquez, Barbara Neistadt, et al.Breast Cancer Research and Treatment|November 28, 2014
Inherited predisposition to breast cancer among African American womenJane E Churpek, Tom Walsh, Yonglan Zheng, et al.Blood Advances|January 25, 2018
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignanciesMichael W Drazer, Sabah Kadri, Madina Sukhanova, et al.The Journal of Molecular Diagnostics : JMD|November 6, 2013
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimensColin C Pritchard, Stephen J Salipante, Karen Koehler, et al.Clinical Lymphoma, Myeloma & Leukemia|May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline UpdateHedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, et al.Pageof 6